- Home
- TNGX vs NBH Comparison
TNGX vs NBH Comparison
Compare TNGX & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NBH
- Stock Information
- Founded
- TNGX 2014
- NBH 2002
- Country
- TNGX United States
- NBH United States
- Employees
- TNGX N/A
- NBH N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- TNGX Health Care
- NBH Finance
- Exchange
- TNGX Nasdaq
- NBH Nasdaq
- Market Cap
- TNGX 351.2M
- NBH 288.5M
- IPO Year
- TNGX N/A
- NBH N/A
- Fundamental
- Price
- TNGX $6.01
- NBH $9.87
- Analyst Decision
- TNGX Strong Buy
- NBH
- Analyst Count
- TNGX 6
- NBH 0
- Target Price
- TNGX $12.20
- NBH N/A
- AVG Volume (30 Days)
- TNGX 2.7M
- NBH 85.9K
- Earning Date
- TNGX 08-06-2025
- NBH 01-01-0001
- Dividend Yield
- TNGX N/A
- NBH 4.34%
- EPS Growth
- TNGX N/A
- NBH N/A
- EPS
- TNGX N/A
- NBH 0.12
- Revenue
- TNGX $40,990,000.00
- NBH N/A
- Revenue This Year
- TNGX N/A
- NBH N/A
- Revenue Next Year
- TNGX N/A
- NBH N/A
- P/E Ratio
- TNGX N/A
- NBH $87.04
- Revenue Growth
- TNGX 10.09
- NBH N/A
- 52 Week Low
- TNGX $1.03
- NBH $8.75
- 52 Week High
- TNGX $12.02
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- NBH 47.91
- Support Level
- TNGX $5.34
- NBH $9.79
- Resistance Level
- TNGX $6.40
- NBH $9.97
- Average True Range (ATR)
- TNGX 0.50
- NBH 0.06
- MACD
- TNGX -0.02
- NBH 0.01
- Stochastic Oscillator
- TNGX 84.08
- NBH 44.44
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.